Tae Life Sciences

Full-Life Technologies

This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.

Ariceum Therapeutics

This clinical-stage biotechnology company develops targeted radiopharmaceutical therapies for the diagnosis and treatment of aggressive, hard-to-treat cancers.

GT Medical Technologies

This company produces bioresorbable radiotherapy implants for patients with operable brain tumors to deliver targeted radiation immediately following surgical removal.

CollimateHealth

This company develops microbeam radiation technology for oncology clinics to treat cancer tumours through high-dose, narrow beams that activate immune responses.

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

Astral Systems

The company develops compact nuclear fusion reactors for healthcare providers and researchers to produce medical radioisotopes for cancer diagnosis and treatment.

Cereius

This company develops targeted radiopharmaceuticals and radiodiagnostics for cancer patients, focusing on the treatment of solid tumour brain metastases.

Alpha Tau Medical

This oncology company develops intratumoral alpha-emitting radiation therapy devices to treat patients with solid tumours.